News
Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.
The National Weather Service issued a report at 9:14 p.m. EDT on Tuesday for strong thunderstorms until 10 p.m. EDT for St.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...
This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...
Gilead Sciences Inc. closed 9.97% short of its 52-week high of $119.96, which the company reached on March 10th.
Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.
Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...
A man who could be facing the death penalty in the death of a Morrow County sheriff’s deputy had his second arraignment ...
In celebration of fathers, the Balm of Gilead Alternative Clinic, in collaboration with the New Tafo PIWC, held the second edition of the Legacy Fathers’ Awards to honour servicemen in Kumasi. The ...
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a significant setback after the US Food and Drug Administration put on hold ...
WWI pandemic is explored in The Flu That Killed 50 Million, Murder 24/7 returns for a new run, there's the New Zealand ...
Gilead is laying off 36 people as part of a rethink that saw the Big Pharma scrap plans to expand a biologics facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results